STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 81 filers reported holding STEMLINE THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $283,000 | -58.1% | 58,544 | -7.8% | 0.12% | +5.5% |
| Q4 2019 | $675,000 | +32.6% | 63,484 | +29.8% | 0.11% | +6.8% |
| Q3 2019 | $509,000 | -41.8% | 48,906 | -14.4% | 0.10% | -44.0% |
| Q2 2019 | $875,000 | +153.6% | 57,127 | +112.7% | 0.18% | -74.9% |
| Q1 2019 | $345,000 | +22.3% | 26,854 | -9.7% | 0.73% | +1429.2% |
| Q4 2018 | $282,000 | -36.5% | 29,723 | +11.2% | 0.05% | +4.3% |
| Q3 2018 | $444,000 | -39.7% | 26,741 | -41.7% | 0.05% | -92.9% |
| Q2 2018 | $736,000 | -7.0% | 45,850 | -11.3% | 0.65% | -5.1% |
| Q1 2018 | $791,000 | +111.5% | 51,678 | +115.7% | 0.69% | +46.3% |
| Q4 2017 | $374,000 | – | 23,958 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 315,980 | $3,381,000 | 1.62% |
| VHCP Management, LLC | 135,420 | $1,449,000 | 1.56% |
| Eventide Asset Management | 851,400 | $9,110,000 | 0.59% |
| CARL DOMINO INC | 26,000 | $278,000 | 0.30% |
| SABBY MANAGEMENT, LLC | 357,806 | $3,829,000 | 0.22% |
| Telemetry Investments, L.L.C. | 25,016 | $268,000 | 0.15% |
| J. Goldman & Co LP | 199,886 | $2,139,000 | 0.14% |
| BAILARD, INC. | 123,785 | $1,324,000 | 0.12% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 94,945 | $1,015,000 | 0.07% |
| Candriam S.C.A. | 244,000 | $2,611,000 | 0.06% |